Neem leaf glycoprotein helps to generate carcinoembryonic antigen specific anti-tumor immune responses utilizing macrophage-mediated antigen presentation.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Vaccine

• Publication date

  2008-08-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2008.06.048PMID 18590789
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance.

  2008cited by this paper
• Antibody response against neem leaf preparation recognizes carcinoembryonic antigen.

  2007cited by this paper
• Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen.

  2007cited by this paper
• Neem leaf preparation induces apoptosis of tumor cells by releasing cytotoxic cytokines from human peripheral blood mononuclear cells

  2007cited by this paper
• Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.

  2007cited by this paper
• Prophylactic Dose of Neem (Azadirachta indica) Leaf Preparation Restricting Murine Tumor Growth is Nontoxic, Hematostimulatory and Immunostimulatory

  2006cited by this paper
• Interferon alpha2b augments suppressed immune functions in tobacco-related head and neck squamous cell carcinoma patients by modulating cytokine signaling.

  2006cited by this paper
• Peroral IMUNOR®, A Low-Molecular-Weight Immunomodulator Prepared from Disintegrated and Ultrafiltered Leukocytes, Enhances Recovery from Myelosuppression Induced by Cisplatin or 5-Fluorouracil

  2006cited by this paper
• Tumor vaccine: current trends in antigen specific immunotherapy.

  2005cited by this paper
• Immunostimulatory neem leaf preparation acts as an adjuvant to enhance the efficacy of poorly immunogenic B16 melanoma surface antigen vaccine.

  2005cited by this paper
• Dendritic Cells Pulsed with an Anti-Idiotype Antibody Mimicking Carcinoembryonic Antigen (CEA) Can Reverse Immunological Tolerance to CEA and Induce Antitumor Immunity in CEA Transgenic Mice

  2004cited by this paper
• Immunology and immunotherapy of colorectal cancer.

  2003cited by this paper
• Amplification of virus-induced antimelanoma T-cell reactivity by high-dose interferon-alpha2b: implications for cancer vaccines.

  2003cited by this paper
• Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigen

  2003cited by this paper
• Identification of tumour-associated t-cell epitopes for vaccine development

  2002cited by this paper
• Antigen Presentation by Murine Peritoneal Cavity Macrophage-Derived Dendritic Cells

  2001cited by this paper
• Dendritic cells in cancer vaccines.

  2001cited by this paper
• A new mouse model for evaluating the immunotherapy of human colorectal cancer.

  2001cited by this paper
• Miscellaneous Analytical Methods

  2001cited by this paper
• Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine

  2000cited by this paper
• A novel in vitro model of early human adult B lymphopoiesis that allows proliferation of pro-B cells and differentiation to mature B lymphocytes

  2000cited by this paper
• Dynamic Interactions of Macrophages with T Cells during Antigen Presentation

  1999cited by this paper
• Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.

  1999cited by this paper
• The macrophage--a cell for all seasons.

  1999cited by this paper
• Signal transduction by immunoglobulin Fc receptors

  1998cited by this paper
• Qualitative Regulation of B Cell Antigen Receptor Signaling by CD19: Selective Requirement for PI3-Kinase Activation, Inositol-1,4,5-Trisphosphate Production and Ca2+ Mobilization

  1997cited by this paper
• Transcription factor Egr-1 activity down-regulates Fas and CD23 expression in B cells.

  1997cited by this paper
• The Macrophage Scavenger Receptor Type A Is Expressed by Activated Macrophages and Protects the Host Against Lethal Endotoxic Shock

  1997cited by this paper
• Macrophages in host defense mechanisms.

  1996cited by this paper
• Carcinoembryonic antigen as a target for cancer vaccines

  1996cited by this paper
• IFN-gamma priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and MRNA stability.

  1995cited by this paper
• The demonstration of an essential role for macrophages in the in vivo generation of IgG2a antibodies

  1994cited by this paper
• Germline transcripts of the murine immunoglobulin γ2a gene: structure and induction by IFN-γ

  1993cited by this paper
• The macrophage response to infectious agents: mechanisms of macrophage activation and tumour cell killing.

  1993cited by this paper
• Germline transcripts of the murine immunoglobulin gamma 2a gene: structure and induction by IFN-gamma.

  1993cited by this paper
• The biochemistry and cell biology of antigen processing and presentation.

  1993influential reference
• Macrophages as accessory cells in the in vivo humoral immune response: from processing of particulate antigens to regulation by suppression.

  1992cited by this paper
• Induction of colorectal cancer in rats by 20-methylcholanthrene.

  1992cited by this paper
• Macrophages as accessory cells in the in vivo humoral immune response: from processing of particulate antigens to regulation by suppression.

  1992cited by this paper
• Antigen presentation to B cells.

  1991cited by this paper
• Techniques in protein chemistry

  1989cited by this paper
• Biochemistry and biology of antigen presentation by macrophages.

  1986cited by this paper
• Definition by monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues.

  1985cited by this paper
• The cell biology of macrophage activation.

  1984cited by this paper
• Carcinoembryonic antigen as a monitor of successful surgical resection in 130 patients with carcinoma of the lung.

  1978cited by this paper
• Carcinoembryonic antigen in breast cancer patients: Serum levels and disease progress

  1974cited by this paper
• Cytochemical identification of monocytes and granulocytes.

  1971cited by this paper

• Immunomodulatory effects of Diospyros peregrina fruit preparation (DFP) in non-small cell lung cancer (NSCLC) by utilizing dendritic cell-mediated antigen presentation and T helper (TH) cell differentiation

  2024cites this paper
• Neem leaf glycoprotein binding to Dectin-1 receptors on dendritic cell induces type-1 immunity through CARD9 mediated intracellular signal to NFκB

  2024cites this paper
• Pharmacognosy of Azadirachta indica and possible use in COVID- 19: a review

  2023cites this paper
• Immunomodulatory Role of Diospyros peregrina Fruit Preparation in Breast Cancer by Utilizing Macrophage Mediated Antigen Presentation and T Helper Cell (Th) Differentiation.

  2023cites this paper
• Exploring the therapeutic potential of Neem (Azadirachta Indica) for the treatment of prostate cancer: a literature review

  2022cites this paper
• Neem Leaf Glycoprotein in immunoregulation of cancer.

  2022cites this paper
• NLGP regulates RGS5‐TGFβ axis to promote pericyte‐dependent vascular normalization during restricted tumor growth

  2022cites this paper
• Azadirachta indica ( neem )-GreenTreasure

  2022cites this paper
• Functionalized iron oxide nanoparticles conjugate of multi-anchored Schiff’s base inorganic heterocyclic pendant groups: Cytotoxicity studies

  2020cites this paper
• Possible role of traditional medicinal plant Neem (Azadirachta indica) for the management of COVID-19 infection

  2020cites this paper
• Human‐lymphocyte cell friendly starch–hydroxyapatite biodegradable composites: Hydrophilic mechanism, mechanical, and structural impact

  2020cites this paper
• Neem Leaf Glycoprotein in Cancer Immunomodulation and Immunotherapy

  2019cites this paper
• Neem Leaf Glycoprotein Facilitates Lung Carcinoma- Associated Antigen-Specific Anti-Cancer Immune Response Utilizing Macrophage-Mediated Antigen Presentation and Induction of Type 1 Cytokines Coupled with Nitric Oxide Production

  2019cites this paper
• NLGP counterbalances the immunosuppressive effect of tumor-associated mesenchymal stem cells to restore effector T cell functions

  2019cites this paper
• Chapter 7 Neem and Prostate Cancer Therapy

  2016cites this paper
• Absence of CD4(+) T cell help generates corrupt CD8(+) effector T cells in sarcoma-bearing Swiss mice treated with NLGP vaccine.

  2016cites this paper
• Neem leaf glycoprotein regulates function of tumor associated M2 macrophages in hypoxic tumor core: Critical role of IL-10/STAT3 signaling.

  2016cites this paper
• Neem leaf glycoprotein promotes dual generation of central and effector memory CD8(+) T cells against sarcoma antigen vaccine to induce protective anti-tumor immunity.

  2016cites this paper
• Therapeutic anti-NLGP monoclonal antibody for carcinoembryonic antigen expressing tumors is nontoxic to Swiss and BALB/c mice.

  2015cites this paper
• Neem leaf glycoprotein optimizes effector and regulatory functions within tumor microenvironment to intervene therapeutically the growth of B16 melanoma in C57BL/6 mice

  2015cites this paper
• Azadirachta indica (Neem) and Neem Limonoids as Anticancer Agents: Molecular Mechanisms and Targets

  2014cites this paper
• Immunotherapeutic targeting of established sarcoma in Swiss mice by tumor-derived antigen-pulsed NLGP matured dendritic cells is CD8+ T-cell dependent.

  2014cites this paper
• A Monoclonal Antibody Against Neem Leaf Glycoprotein Recognizes Carcinoembryonic Antigen (CEA) and Restricts CEA Expressing Tumor Growth

  2014cites this paper
• Neem components as potential agents for cancer prevention and treatment.

  2014influential citation
• CHEMICAL INVESTIGATION OF NEEM LEAF GLYCOPROTEIN USED AS IMMUNOPROPHYLACTIC AGENT FOR TUMOR GROWTH RESTRICTION

  2014cites this paper
• Normalization of Tumor Microenvironment by Neem Leaf Glycoprotein Potentiates Effector T Cell Functions and Therapeutically Intervenes in the Growth of Mouse Sarcoma

  2013cites this paper
• Neem leaf glycoprotein is nontoxic to physiological functions of Swiss mice and Sprague Dawley rats: histological, biochemical and immunological perspectives.

  2013cites this paper
• Neem leaf glycoprotein is superior than cisplatin and sunitinib malate in restricting melanoma growth by normalization of tumor microenvironment.

  2013cites this paper
• Neem Leaf Glycoprotein Activates CD8+ T Cells to Promote Therapeutic Anti-Tumor Immunity Inhibiting the Growth of Mouse Sarcoma

  2013cites this paper
• Neem leaf glycoprotein suppresses regulatory T cell mediated suppression of monocyte/macrophage functions.

  2012cites this paper
• Natural products: promising resources for cancer drug discovery.

  2012cites this paper
• Effect of Neem Leaf Extract (Azadirachta indica) on c-Myc Oncogene Expression in 4T1 Breast Cancer Cells of BALB/c Mice

  2012cites this paper
• Neem Leaf Glycoprotein Partially Rectifies Suppressed Dendritic Cell Functions and Associated T Cell Efficacy in Patients with Stage IIIB Cervical Cancer

  2011cites this paper
• Archive of SID Extract of Azadirachta indica (Neem) Leaf Induces Apoptosis in 4T1 Breast Cancer BALB/c Mice

  2011cites this paper
• Anticancer biology of Azadirachta indica L (neem): A mini review

  2011cites this paper
• Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+ Tregs to restrict murine tumor growth.

  2011cites this paper
• Extract of Azadirachta indica (Neem) Leaf Induces Apoptosis in 4T1 Breast Cancer BALB/c Mice

  2011cites this paper
• Restoration of dysregulated CC chemokine signaling for monocyte/macrophage chemotaxis in head and neck squamous cell carcinoma patients by neem leaf glycoprotein maximizes tumor cell cytotoxicity

  2010cites this paper
• Neem Tree Assessment for Socioeconomic Empowerment in Rural Burkina Faso

  2010cites this paper
• Pre-operative intracellular glutathione levels of peripheral monocytes as a biomarker to predict survival of colorectal cancer patients

  2010cites this paper
• Neem leaf glycoprotein enhances carcinoembryonic antigen presentation of dendritic cells to T and B cells for induction of anti-tumor immunity by allowing generation of immune effector/memory response.

  2010cites this paper
• Neem leaf glycoprotein matures myeloid derived dendritic cells and optimizes anti-tumor T cell functions.

  2010cites this paper
• The Tat‐conjugated N‐terminal region of mucin antigen 1 (MUC1) induces protective immunity against MUC1‐expressing tumours

  2009cites this paper
• Neem Leaf Glycoprotein Induces Perforin-mediated Tumor Cell Killing by T and NK Cells Through Differential Regulation of IFNγ Signaling

  2009cites this paper
• Induction of type 1 cytokines during neem leaf glycoprotein assisted carcinoembryonic antigen vaccination is associated with nitric oxide production.

  2009cites this paper
• Protective anti‐tumour immune responses by murine dendritic cells pulsed with recombinant Tat‐carcinoembryonic antigen derived from Escherichia coli

  2009cites this paper